Active transport

Why special transport systems are needed

Not all molecules can easily cross the lipid bilayer of the cell membrane via simple passive diffusion. To transport specific groups of substances, the cell utilizes specialized carrier proteins (transportatores) that span the membrane entirely.

Such systems are required by:

• Hydrophilic compounds, as they are physically insoluble in the lipids of the cell wall.
• High-molecular-weight compounds, whose size significantly exceeds the diameter of membrane pores.

Physiologically, these transport proteins perform two overarching tasks. First, they ensure the influx (Influx) of vital nutrients such as amino acids, vitamins, or sugars into the cell. Second, they guarantee efflux (Efflux)—the removal of endogenous metabolic waste products, toxins, and various xenobiotics.

Molecular mechanism of active transport

The key element of the process is the membrane carrier protein (proteinum transportans). The mechanism of its action is a strict sequence of steps:

1. On one side of the membrane, the transported substance is recognized and binds to the active site of the carrier protein.
2. Hydrolysis of a high-energy compound occurs—the cleavage of an ATP molecule (Adenosinum triphosphatum) into ADP (Adenosinum diphosphatum) and inorganic phosphate. The energy from the cleaved phosphate bond is transferred to the transport system.
3. Driven by the acquired energy, the protein changes its spatial structure (a conformational change occurs).
4. The substance is transported across the membrane barrier.
5. The binding affinity between the molecule and the carrier drops, after which the substrate is released on the opposite side of the membrane—into the cytoplasm or interstitial space.

Classification by energy source

Since active transport always proceeds against the concentration gradient, it continually requires energy. Depending on the exact source of this energy, two types of transport are distinguished.

Primary active transport Here, the system operates directly from "cellular batteries". Energy for substrate transfer is released directly during the hydrolysis of an ATP molecule.

Secondary active transport This type of transport relies on coupling. Energy is derived from the transfer of another ion (most commonly a sodium ion, $Na^+$), which moves along its electrochemical gradient. It is important to note that this sodium gradient itself is previously established by the activity of the $Na^+, K^+$-ATPase. Meanwhile, the transported substance itself "rides" against its gradient.

Secondary transport is additionally subdivided by the direction of particle movement:

• Symport (cotransport): the sodium ion and the target substance move strictly in the same direction.
• Antiport: the sodium ion and the substance move in opposite, counter directions.

Facilitated diffusion (Diffusio facilitata)

Facilitated diffusion is a related process that is often considered together with active transport because it also requires a carrier protein. A classic example of such a mechanism is glucose transport into cells.

Main difference: the process proceeds along the concentration gradient (from higher to lower concentration), so it does not require metabolic energy expenditure at all.

Similarities with active transport:

• The mechanism of interaction with the membrane protein is identical (binding, conformational change, release).
• It exhibits strict specificity for the transported molecules.
• It is characterized by saturability (the rate is limited by the number of free carriers).

Pharmacological significance: how drugs penetrate tissues

Normally, transport systems are intended exclusively for "native", endogenous substances—sugars, iron, purine bases, or amino acids. A medicinal product (medicamentum) cannot simply make use of a carrier protein.

The main condition for drug transport is the presence of chemical similarity between the drug molecule and the body's natural endogenous substrates. The drug must literally mimic a natural substance so that the transporter protein mistakes it for a "native" one.

A striking clinical example of such molecular deception is the antiparkinsonian drug Levodopa (dihydroxyphenylalanine). To penetrate the brain through the dense blood-brain barrier (BBB), levodopa mimics a natural amino acid. As a result, it is successfully transported across the barrier via a specific aromatic amino acid transporter protein.

Briefly: answers to topical questions

Class and exam questions

What else to study on this topic

• Localization of transport proteins in barrier tissues (intestinal epithelium, hepatocytes, renal tubules)
• Characteristics of the two main transport protein superfamilies
• The role of Na+, K+-ATPase in powering secondary active transport
• Cellular efflux mechanisms and resistance to xenobiotics

Other topics in "General Pharmacology"

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.